CN1085668C - 6－[三唑基[3－(三氟甲基)苯基]甲基]－2－喹啉酮和喹啉硫酮 - Google Patents

6－[三唑基[3－(三氟甲基)苯基]甲基]－2－喹啉酮和喹啉硫酮 Download PDF

Info

Publication number
CN1085668C
CN1085668C CN95197162A CN95197162A CN1085668C CN 1085668 C CN1085668 C CN 1085668C CN 95197162 A CN95197162 A CN 95197162A CN 95197162 A CN95197162 A CN 95197162A CN 1085668 C CN1085668 C CN 1085668C
Authority
CN
China
Prior art keywords
compound
formula
following formula
methyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95197162A
Other languages
English (en)
Chinese (zh)
Other versions
CN1171789A (zh
Inventor
M·G·维尼特
D·J·P·马拜尔
G·C·桑兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN1171789A publication Critical patent/CN1171789A/zh
Application granted granted Critical
Publication of CN1085668C publication Critical patent/CN1085668C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
CN95197162A 1994-12-28 1995-12-21 6－[三唑基[3－(三氟甲基)苯基]甲基]－2－喹啉酮和喹啉硫酮 Expired - Fee Related CN1085668C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203773.0 1994-12-28
EP94203773 1994-12-28

Publications (2)

Publication Number Publication Date
CN1171789A CN1171789A (zh) 1998-01-28
CN1085668C true CN1085668C (zh) 2002-05-29

Family

ID=8217501

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95197162A Expired - Fee Related CN1085668C (zh) 1994-12-28 1995-12-21 6－[三唑基[3－(三氟甲基)苯基]甲基]－2－喹啉酮和喹啉硫酮

Country Status (25)

Country Link
US (1) US5922734A (enExample)
EP (1) EP0800524B1 (enExample)
JP (1) JPH10511654A (enExample)
CN (1) CN1085668C (enExample)
AR (1) AR002264A1 (enExample)
AT (1) ATE207924T1 (enExample)
AU (1) AU698199B2 (enExample)
BR (1) BR9510504A (enExample)
CA (1) CA2207268A1 (enExample)
DE (1) DE69523629T2 (enExample)
DK (1) DK0800524T3 (enExample)
ES (1) ES2166838T3 (enExample)
FI (1) FI972794A7 (enExample)
HR (1) HRP950616A2 (enExample)
IL (1) IL116577A (enExample)
MY (1) MY131690A (enExample)
NO (1) NO311220B1 (enExample)
NZ (1) NZ298789A (enExample)
PL (1) PL182956B1 (enExample)
PT (1) PT800524E (enExample)
RU (1) RU2165419C2 (enExample)
TR (1) TR199501688A2 (enExample)
TW (1) TW316902B (enExample)
WO (1) WO1996020200A1 (enExample)
ZA (1) ZA9510989B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
US6420555B1 (en) 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
AU4822299A (en) * 1998-06-16 2000-01-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Imidazolyl derivatives
EP1420015A1 (en) * 1999-06-11 2004-05-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Imidazolyl derivatives
EP1339709B1 (en) * 2000-11-21 2009-06-24 Janssen Pharmaceutica N.V. Farnesyl transferase inhibiting benzoheterocyclic derivatives
DE60118953T2 (de) * 2000-11-28 2007-01-11 Janssen Pharmaceutica N.V. Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung
ATE319704T1 (de) * 2000-12-27 2006-03-15 Janssen Pharmaceutica Nv Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
JP4351444B2 (ja) * 2000-12-27 2009-10-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ファルネシルトランスフェラーゼを阻害する４−ヘテロシクリル−キノリンおよびキナゾリン誘導体
WO2009151683A2 (en) * 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260744A2 (en) * 1986-09-15 1988-03-23 Janssen Pharmaceutica N.V. (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives
EP0371564A2 (en) * 1988-11-29 1990-06-06 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives
EP0609963A1 (en) * 1988-11-29 1994-08-10 Janssen Pharmaceutica N.V. Use of benzimidazoles and benzotriazoles in the treatment of epithelial disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) * 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
US4859684A (en) * 1986-09-15 1989-08-22 Janssen Pharmaceutica N.V. (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
DK391189A (da) * 1988-08-10 1990-02-11 Otsuka Pharma Co Ltd Carbostyrilderivater
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
US5185346A (en) * 1988-11-29 1993-02-09 Hanssen Pharmaceutica (1H-azol-1-ylmethyl)substituted quinoline derivatives
CA2015267A1 (en) * 1989-05-26 1990-11-26 Rainer Seele 8-azolylmethylquinolines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260744A2 (en) * 1986-09-15 1988-03-23 Janssen Pharmaceutica N.V. (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives
EP0371564A2 (en) * 1988-11-29 1990-06-06 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives
EP0609963A1 (en) * 1988-11-29 1994-08-10 Janssen Pharmaceutica N.V. Use of benzimidazoles and benzotriazoles in the treatment of epithelial disorders

Also Published As

Publication number Publication date
IL116577A (en) 2000-02-29
FI972794L (fi) 1997-06-27
NO973029D0 (no) 1997-06-27
FI972794A0 (fi) 1997-06-27
PL321041A1 (en) 1997-11-24
JPH10511654A (ja) 1998-11-10
TR199501688A2 (tr) 1996-07-21
NO311220B1 (no) 2001-10-29
BR9510504A (pt) 1999-06-01
NO973029L (no) 1997-06-27
AU4436296A (en) 1996-07-19
CN1171789A (zh) 1998-01-28
AR002264A1 (es) 1998-03-11
MX9704667A (es) 1997-09-30
PL182956B1 (pl) 2002-05-31
DE69523629D1 (de) 2001-12-06
MY131690A (en) 2007-08-30
ZA9510989B (en) 1997-06-27
HRP950616A2 (en) 1997-10-31
US5922734A (en) 1999-07-13
AU698199B2 (en) 1998-10-29
DK0800524T3 (da) 2002-03-25
FI972794A7 (fi) 1997-06-27
ES2166838T3 (es) 2002-05-01
WO1996020200A1 (en) 1996-07-04
IL116577A0 (en) 1996-03-31
CA2207268A1 (en) 1996-07-04
RU2165419C2 (ru) 2001-04-20
EP0800524A1 (en) 1997-10-15
ATE207924T1 (de) 2001-11-15
TW316902B (enExample) 1997-10-01
PT800524E (pt) 2002-04-29
NZ298789A (en) 1999-07-29
DE69523629T2 (de) 2002-07-18
EP0800524B1 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
JP3404749B2 (ja) Ｎ―［４―（ヘテロアリールメチル）フェニル］―ヘテロアリールアミン
JP3488922B2 (ja) ホスホジエステラーゼ阻害剤としての１，３−ジヒドロ−２Ｈ−イミダゾ（４，５−ｂ）キノリン−２−オン誘導体類
CN1091596C (zh) 抗真菌剂及其化合物和它们的制备方法
LU85743A1 (fr) Composes heterocycliques
JP2001525400A (ja) レチノイン酸擬似アニリド
JP2013541578A (ja) １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
US7820650B2 (en) Antifungal 4-substituted 5,6-dihydro-4H-pyrrolo [1,2-a][1,4]benzodiazepines
CN1085668C (zh) 6－[三唑基[3－(三氟甲基)苯基]甲基]－2－喹啉酮和喹啉硫酮
JP3278738B2 (ja) 抗真菌剤
EP3704097B1 (en) Bicyclic sulfones and sulfoxides and methods of use thereof
WO1998037070A1 (en) Fused ring compounds, process for producing the same and use thereof
JPH11507631A (ja) １ｈ−４（５）−置換イミダゾール誘導体
JPH05194436A (ja) ４−〔４−〔４−（４−ヒドロキシフエニル）−１−ピペラジニル〕フエニル〕−５−メチル−３ｈ−１，２−４−トリアゾロ−３−ン誘導体類
CN1141042A (zh) 旋光对映纯的(+)-利罗唑
MXPA97004667A (en) 6- [triazolil [3-trifluoromethyl) phenyl] methyl] -2-quinolinones and quinolinotium
AU688852B2 (en) Enantiomerically pure(-)-liarozole
JPH10195056A (ja) 縮合ベンゼン誘導体、その製造法および剤
WO2024243692A1 (en) Cyp26b1 inhibitor compounds and methods of use thereof
HK40041775B (zh) 三氮唑类化合物及其制备方法与用途
JP2002179677A (ja) 光学活性イミダゾリルアセトニトリル誘導体及びその製造方法
JPH08502985A (ja) 治療剤
JPH0977750A (ja) 新規な光学活性トリアゾール誘導体又はその塩類、その製造方法及び抗真菌剤並びにその使用方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee